Takashi Yokota
Overview
Explore the profile of Takashi Yokota including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
227
Citations
3411
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kubo T, Sugiura K, Tokita Y, Takano H, Takamisawa I, Takayama M, et al.
Heart
. 2025 Mar;
PMID: 40037766
Background: The Japanese Hypertrophic Cardiomyopathy Registry Study was designed to provide comprehensive, real-world insights into the clinical characteristics and management of hypertrophic cardiomyopathy (HCM) in Japan. Methods: This multicentre, prospective...
2.
Imaizumi T, Yokota T, Funakoshi K, Yasuda K, Hattori A, Morohashi A, et al.
Clin Exp Nephrol
. 2025 Jan;
PMID: 39762534
Background: Identifying patients on dialysis among those with an estimated glomerular filtration rate (eGFR) < 15 mL/min/1.73 m remains challenging. To facilitate clinical research in advanced chronic kidney disease (CKD)...
3.
Abe T, Inao T, Shingu Y, Yamada A, Takada S, Fukushima A, et al.
Eur J Cardiothorac Surg
. 2024 Dec;
67(1).
PMID: 39689034
Objectives: Sarcopenia and malnutrition often occur simultaneously in adults with cardiovascular diseases. Our objective was to determine the associations of preoperative sarcopenia and malnutrition with major adverse cardiac and cerebral...
4.
Hanada K, Sasaki S, Kinjo T, Shikanai S, Yamazaki K, Kato T, et al.
Circ J
. 2024 Oct;
89(3):354-363.
PMID: 39401921
Background: Although the efficacy of an implantable cardioverter defibrillator (ICD) in preventing sudden cardiac death is well established, the incidence and predictors of appropriate ICD therapy in Japanese ischemic heart...
5.
Yokota T, Kinugawa S, Fukushima A, Okumura T, Murohara T, Tsutsui H
Heart Vessels
. 2024 Aug;
40(2):111-122.
PMID: 39158751
Hyperuricemia is an independent predictor of mortality in patients with chronic heart failure (CHF). To determine whether febuxostat, a urate-lowering agent, may improve clinical outcomes in CHF patients, we conducted...
6.
Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients
Osawa H, Nakamura N, Tsutaya C, Saitoh H, Shimada M, Murakami R, et al.
In Vivo
. 2024 Apr;
38(3):1351-1358.
PMID: 38688654
Background/aim: The pathogenesis of cardio-vascular disease (CVD) in hemodialysis (HD) patients involves inflammation and oxidative stress. High-sensitivity C-reactive protein (hs-CRP) is an established inflammatory biomarker associated with CVD. Several studies...
7.
8.
Natsui H, Watanabe M, Yokota T, Tsuneta S, Fumoto Y, Handa H, et al.
Physiol Rep
. 2024 Mar;
12(6):e15957.
PMID: 38546216
Epicardial adipose tissue (EAT) is an active endocrine organ that is closely associated with occurrence of atrial fibrillation (AF). However, the role of EAT in the development of postoperative AF...
9.
Shirakawa R, Nakajima T, Yoshimura A, Kawahara Y, Orito C, Yamane M, et al.
Sci Rep
. 2024 Mar;
14(1):6786.
PMID: 38514680
No abstract available.
10.
Okita K, Omokawa M, Takada S, Kadoguchi T, Morita N, Yokota T
Acta Physiol (Oxf)
. 2024 Jan;
240(3):e14097.
PMID: 38230807
Aim: We compared muscular metabolic stress during exercise performed at multiple intensities, from very low to moderate, with blood flow restriction (BFR) adjusted by the same work volume. Methods: Twenty-five...